Novo Nordisk A/S NVO
NYSE
Recommendation
Dividend Power Score
Day's Range
$40.64$41.80
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.83% | 4.48% | 37.66% | 0.74% | 11.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.83% | 4.48% | 37.66% | 0.74% | 11.77% |
| Cost of Revenue | -22.17% | 36.19% | 17.12% | 28.12% | 68.31% |
| Gross Profit | 11.98% | -1.88% | 41.72% | -3.75% | 1.11% |
| SG&A Expenses | -10.63% | -11.49% | -8.93% | -7.77% | 14.56% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1,402.16% | 940.89% | 940.58% | -137.12% | 23.14% |
| Total Operating Expenses | -9.02% | 6.30% | 5.12% | 24.74% | 45.45% |
| Operating Income | 31.66% | 2.13% | 70.63% | -18.74% | -25.57% |
| Income Before Tax | -17.43% | -18.66% | 86.39% | 4.85% | -21.11% |
| Income Tax Expenses | -16.28% | -17.53% | 88.97% | 8.57% | -17.29% |
| Earnings from Continuing Operations | -17.75% | -18.98% | 85.68% | 3.89% | -22.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.75% | -18.98% | 85.68% | 3.89% | -22.10% |
| EBIT | 31.66% | 2.13% | 70.63% | -18.74% | -25.57% |
| EBITDA | 26.51% | 1.76% | 64.72% | -16.50% | -18.61% |
| EPS Basic | -17.00% | -18.63% | 85.56% | 3.95% | -21.99% |
| Normalized Basic EPS | 17.19% | 0.91% | 86.27% | -11.02% | -21.00% |
| EPS Diluted | -17.21% | -18.77% | 85.50% | 3.99% | -21.83% |
| Normalized Diluted EPS | 16.75% | 0.75% | 86.29% | -10.95% | -20.86% |
| Average Basic Shares Outstanding | -0.91% | -0.42% | 0.07% | -0.06% | -0.15% |
| Average Diluted Shares Outstanding | -0.54% | -0.25% | 0.05% | -0.14% | -0.31% |
| Dividend Per Share | -- | 2.31% | -- | 9.75% | -- |
| Payout Ratio | 0.19% | -- | -0.40% | -- | 0.46% |